High-Yield One-Liner Exam Points

Medexamium Dr.Myo
  1. Acetylcholine is the universal neurotransmitter at all preganglionic synapses (both sympathetic and parasympathetic) and at parasympathetic postganglionic endings.

  2. Pilocarpine is a direct-acting muscarinic agonist used in glaucoma to cause miosis and reduce intraocular pressure.

  3. Neostigmine reversibly inhibits acetylcholinesterase, increasing ACh at the neuromuscular junction to improve muscle strength.

  4. SLUD (Salivation, Lacrimation, Urination, Defecation) represents muscarinic overstimulation seen in cholinergic toxicity (organophosphate poisoning).

  5. Carbachol is a carbamic acid ester resistant to hydrolysis by acetylcholinesterase, giving it a longer duration of action.

  6. Atropine competitively blocks muscarinic receptors, counteracting the excess acetylcholine caused by organophosphate-induced cholinesterase inhibition.

  7. Scopolamine (hyoscine) crosses the blood-brain barrier effectively and acts on the vestibular system to prevent motion sickness.

  8. Ipratropium is an inhaled anticholinergic bronchodilator that blocks muscarinic receptors in bronchial smooth muscle.

  9. Anticholinergics block muscarinic receptors, reducing secretions and causing dry mouth (xerostomia).

  10. Tropicamide is a short-acting muscarinic antagonist that blocks pupillary constrictor and ciliary muscles, causing mydriasis (pupil dilation) and cycloplegia for fundoscopy.

  11. Hexamethonium is a prototype ganglionic blocker that competitively inhibits nicotinic receptors at autonomic ganglia (both sympathetic and parasympathetic).

  12. Ganglion blockers prevent sympathetic vasoconstriction reflexes, causing orthostatic hypotension.

  13. Epinephrine (adrenaline) is a non-selective catecholamine that activates α1, α2, β1, and β2 receptors.

  14. Epinephrine is first-line for anaphylaxis because it reverses bronchospasm (β2), supports blood pressure (α1), and reduces mediator release.

  15. Phenylephrine is a selective α1-agonist causing vasoconstriction and nasal decongestion.

  16. Oxymetazoline is an α1-agonist that causes nasal mucosal vasoconstriction, reducing congestion.

  17. Dobutamine is a β1-selective agonist that increases cardiac contractility (positive inotropy) with less tachycardia and vasoconstriction than other catecholamines.

  18. Salbutamol (albuterol) selectively activates β2-receptors in bronchial smooth muscle, causing bronchodilation with minimal cardiac effects.

  19. Propranolol is a non-selective beta-blocker that blocks β2-receptors in bronchi, causing bronchoconstriction and worsening asthma.

  20. Metoprolol preferentially blocks β1-receptors (heart) over β2-receptors (lungs), making it safer in patients with mild respiratory disease.

  21. Prazosin is a selective α1-blocker causing vasodilation and reduced peripheral resistance.

  22. First-dose prazosin causes marked orthostatic hypotension due to α1-blockade preventing compensatory vasoconstriction.

  23. Clonidine is a central α2-agonist that reduces sympathetic outflow from the brainstem, lowering blood pressure and heart rate.

  24. Cyclophosphamide alkylates DNA, forming cross-links that prevent replication.

  25. Cyclophosphamide’s metabolite acrolein causes hemorrhagic cystitis.

  26. Methotrexate inhibits dihydrofolate reductase (DHFR), blocking thymidylate and purine synthesis.

  27. Vincristine binds tubulin, preventing microtubule polymerization and arresting cells in metaphase.

  28. Doxorubicin (anthracycline) causes cumulative, dose-dependent cardiomyopathy via free radical generation.

  29. Cisplatin causes dose-limiting nephrotoxicity via direct tubular damage.

  30. Tamoxifen is a SERM that antagonizes estrogen receptors in breast tissue while having agonist effects in bone and uterus.

  31. Cyclooxygenase (COX-1 and COX-2) converts arachidonic acid to prostaglandin H2, the precursor of all prostaglandins and thromboxane.

  32. Misoprostol is a PGE1 analogue that protects gastric mucosa by reducing acid secretion and increasing mucus production.

  33. Latanoprost is a PGF2α analogue that increases uveoscleral outflow, reducing intraocular pressure.

  34. Alprostadil maintains ductus arteriosus patency in neonates with ductal-dependent congenital heart defects until surgical correction.

  35. Tretinoin (all-trans retinoic acid) is a topical retinoid that normalizes follicular keratinization, preventing comedone formation.

  36. Isotretinoin is highly teratogenic (Category X), causing severe craniofacial, cardiac, and CNS defects.

  37. Benzoyl peroxide is an oxidizing agent with bactericidal activity against Propionibacterium acnes.

  38. Permethrin 5% cream is first-line for scabies due to efficacy and safety.

  39. Ivermectin enhances GABA-gated chloride channels in parasites, causing hyperpolarization and paralysis.

  40. Lindane can cause seizures and neurotoxicity, especially in infants (immature BBB) and pregnant women (fetal risk).

  41. Topical corticosteroids are first-line for mild-to-moderate plaque psoriasis due to anti-inflammatory and immunosuppressive effects.

  42. Calcipotriol (vitamin D3 analogue) inhibits keratinocyte proliferation and promotes differentiation, reducing psoriatic scale formation.

  43. Methotrexate is effective for severe psoriasis but causes hepatotoxicity with cumulative doses, requiring LFT monitoring and sometimes liver biopsy.

  44. Ferrous iron (Fe²⁺) is absorbed 3 times better than ferric iron (Fe³⁺) in the duodenum.

  45. Vitamin B12 (cobalamin) deficiency causes megaloblastic anemia with subacute combined degeneration of spinal cord (neurological symptoms).

  46. Chronic kidney disease reduces erythropoietin production.

  47. Folic acid during the periconceptional period (before conception and first trimester) prevents neural tube defects like spina bifida.

  48. Cyclosporine inhibits calcineurin in T lymphocytes, blocking IL-2 production and T-cell activation.

  49. Cyclosporine causes gingival hyperplasia, hirsutism, and nephrotoxicity.

  50. Tacrolimus binds FKBP-12 (FK-binding protein), then inhibits calcineurin.

  51. Tranexamic acid is a lysine analogue that blocks plasminogen’s lysine-binding sites, preventing its conversion to plasmin and subsequent fibrinolysis.

  52. Aminocaproic acid (similar to tranexamic acid) inhibits fibrinolysis, helping maintain clots in hemophilia patients during surgeries.

  53. Hemophilia A is caused by factor VIII deficiency.

  54. Desmopressin stimulates endothelial release of von Willebrand factor and factor VIII, temporarily increasing their plasma levels.

  55. NSAIDs inhibit cyclooxygenase (COX-1 and/or COX-2), reducing prostaglandin synthesis responsible for inflammation, pain, and fever.

  56. Aspirin irreversibly acetylates COX-1 in platelets, inhibiting thromboxane A2 synthesis for the platelet’s lifetime (~10 days).

  57. NSAIDs inhibit gastroprotective prostaglandins (PGE2), reducing mucus and bicarbonate secretion, leading to peptic ulcers and GI bleeding.

  58. Celecoxib selectively inhibits COX-2 (inducible, inflammatory), sparing COX-1 (constitutive, gastroprotective).

  59. Indomethacin inhibits prostaglandin synthesis, promoting ductus arteriosus closure in premature infants.

  60. Bisphosphonates inhibit osteoclast-mediated bone resorption, increasing bone density.

  61. Alendronate must be taken on an empty stomach with plain water, remaining upright for 30-60 minutes to prevent esophageal irritation and ulceration.

  62. Calcitonin directly inhibits osteoclast activity, reducing bone resorption and lowering serum calcium.

  63. Vitamin D deficiency causes rickets in children (defective mineralization of growth plates → bowing of legs) and osteomalacia in adults.

  64. Colchicine inhibits microtubule polymerization in neutrophils, reducing their migration and inflammation in acute gout.

  65. Allopurinol inhibits xanthine oxidase, blocking conversion of hypoxanthine to xanthine and xanthine to uric acid.

  66. Probenecid is a uricosuric agent that inhibits renal tubular reabsorption of uric acid, increasing its excretion.

  67. Starting allopurinol during acute gout can mobilize urate deposits and paradoxically worsen or prolong the attack.

  68. Methotrexate is the anchor DMARD for RA, slowing disease progression.

  69. Leflunomide inhibits dihydroorotate dehydrogenase, blocking pyrimidine synthesis in rapidly dividing lymphocytes.

  70. Hydroxychloroquine can cause irreversible retinal toxicity (bull’s eye maculopathy) with prolonged use, requiring regular ophthalmologic exams.

  71. Succinylcholine is a depolarizing blocker that binds nicotinic receptors, causing initial depolarization (fasciculations) followed by sustained depolarization and paralysis.

  72. Rocuronium is a non-depolarizing (competitive) blocker that competes with ACh at nicotinic receptors without causing depolarization.

  73. Dantrolene blocks ryanodine receptors in skeletal muscle, preventing calcium release and muscle contraction.

  74. Baclofen is a GABA-B agonist that inhibits spinal motor neurons, reducing spasticity in conditions like multiple sclerosis and spinal cord injury.

  75. Cyclobenzaprine is a centrally acting muscle relaxant structurally related to tricyclic antidepressants.

  76. Minoxidil was originally an antihypertensive; its side effect of hypertrichosis led to topical use for pattern baldness.

  77. Finasteride inhibits 5-alpha reductase type II, reducing conversion of testosterone to dihydrotestosterone (DHT), which causes hair follicle miniaturization.

  78. Coal tar reduces keratinocyte proliferation and has anti-inflammatory effects in psoriasis.

  79. Tazarotene binds retinoic acid receptors (RAR-β and RAR-γ), normalizing keratinocyte differentiation and reducing hyperproliferation in psoriasis and acne.

  80. Psoralens are photosensitizing agents that intercalate into DNA; when activated by UVA, they form cross-links that inhibit DNA synthesis in hyperproliferative cells.

  81. Transition mutations involve purine-to-purine (A↔G) or pyrimidine-to-pyrimidine (C↔T) substitutions.

  82. PCR amplifies specific DNA sequences exponentially, enabling detection of minute quantities of genetic material.

  83. Duchenne muscular dystrophy is X-linked recessive, affecting males almost exclusively while females are carriers.

  84. Southern blot detects DNA fragments.

  85. Nonsense mutations create premature stop codons, truncating the protein.

  86. Adenoma is a benign glandular tumor.

  87. Metastasis is the defining hallmark of malignancy.

  88. Grading assesses histological differentiation–how closely tumor cells resemble normal tissue.

  89. In TNM staging: T = primary Tumor size, N = regional lymph Node involvement, M = distant Metastasis.

  90. HER2/NEU (ERBB2) is amplified in ~20% of breast cancers and is a therapeutic target.

  91. P53 monitors DNA damage, halting the cell cycle for repair or triggering apoptosis.

  92. Philadelphia chromosome t(9;22) creates BCR-ABL fusion protein, defining CML.

  93. Carcinoma in situ shows full-thickness dysplasia but intact basement membrane–no invasion.

  94. HPV (types 16, 18) causes >70% of cervical cancers through E6/E7 oncoproteins.

  95. TNF-alpha (cachectin) causes muscle wasting and anorexia in cancer cachexia.

  96. Hereditary spherocytosis results from mutations in red cell membrane proteins (spectrin, ankyrin, band 3).

  97. Sickle cell anemia has glutamic acid replaced by valine at position 6 of β-globin chain (HbS).

  98. Target cells (codocytes) appear in thalassemia, liver disease, and hemoglobinopathies due to excess membrane relative to hemoglobin.

  99. Beta thalassemia minor (trait) is the most prevalent form globally, common in Mediterranean, Middle Eastern, and Asian populations.

  100. G6PD generates NADPH needed to reduce glutathione, which protects RBCs from oxidative stress.

  101. Heinz bodies are denatured hemoglobin precipitates seen in G6PD deficiency after oxidative stress.

  102. PNH results from PIGA gene mutation causing deficient GPI-anchored proteins (CD55, CD59), leading to complement-mediated hemolysis.

  103. Direct Coombs test (DAT) detects antibodies/complement already bound to RBCs (in vivo).

  104. Iron deficiency causes decreased hemoglobin synthesis, producing small (microcytic) and pale (hypochromic) RBCs.

  105. Pica (eating ice, dirt, starch) is characteristic of iron deficiency anemia.

  106. B12 and folate are essential for DNA synthesis.

  107. B12 deficiency causes demyelination of posterior and lateral columns (subacute combined degeneration).

  108. Aplastic anemia shows pancytopenia (low RBCs, WBCs, platelets) with fatty, hypocellular bone marrow.

  109. Chloramphenicol causes dose-dependent and idiosyncratic aplastic anemia.

  110. Schilling test differentiates causes of B12 deficiency by measuring urinary excretion of radiolabeled B12.

  111. JAK2 V617F mutation is found in >95% of polycythemia vera cases, causing constitutive activation of erythropoietin signaling.

  112. Auer rods are crystallized granules seen in myeloid blasts, pathognomonic for AML.

  113. T(15;17) creates PML-RARA fusion in acute promyelocytic leukemia (APL/M3), blocking myeloid differentiation.

  114. CML usually presents in chronic phase with leukocytosis, splenomegaly, and <10% blasts.

  115. MDS shows ineffective hematopoiesis–cells are produced but defective, dying in marrow (intramedullary hemolysis).

  116. Ring sideroblasts have iron-laden mitochondria encircling the nucleus, characteristic of MDS (especially MDS-RS subtype).

  117. Imatinib specifically inhibits BCR-ABL tyrosine kinase, the product of Philadelphia chromosome translocation in CML.

  118. Leukemoid reaction shows high LAP score (reactive neutrophils), while CML has low LAP (neoplastic cells).

  119. Smudge cells are fragile CLL lymphocytes that break during smear preparation.

  120. Acute lymphoblastic leukemia (ALL) is most common pediatric malignancy (peak 2–5 years).

  121. Reed-Sternberg cells are large binucleated cells with “owl-eye” nucleoli, pathognomonic for Hodgkin lymphoma.

  122. Lymphocyte-predominant Hodgkin lymphoma has best prognosis with high lymphocyte count and rare RS cells.

  123. T(14;18) places BCL-2 under immunoglobulin heavy chain promoter, overexpressing anti-apoptotic BCL-2 in follicular lymphoma.

  124. Starry sky pattern shows macrophages (stars) clearing apoptotic tumor cells among sheets of lymphoma cells (sky).

  125. Bence Jones proteins are free immunoglobulin light chains (kappa or lambda) filtered into urine in myeloma.

  126. Rouleaux (stacked coin appearance) forms due to high serum proteins (M-protein) in myeloma, reducing RBC negative charge and causing aggregation.

  127. IgG myeloma is most common (25%).

  128. IgM is a pentamer with high molecular weight, causing hyperviscosity more readily.

  129. Gastric MALT lymphoma arises from chronic H. pylori infection stimulating B-cells.

  130. Diffuse large B-cell lymphoma (DLBCL) is the most common NHL (~30–40%).

  131. Type I (immediate/anaphylactic) hypersensitivity involves IgE bound to mast cells/basophils, releasing histamine upon allergen re-exposure.

  132. Arthus reaction is localized Type III hypersensitivity with immune complex deposition in vessel walls causing vasculitis.

  133. Contact dermatitis is Type IV (delayed-type) hypersensitivity mediated by sensitized T-cells, not antibodies.

  134. CD4+ helper T-cells recognize antigens on MHC Class II (on APCs like macrophages, dendritic cells, B-cells).

  135. C3 is the convergence point for classical, alternative, and lectin pathways.

  136. MAC (C5b-C9) creates pores in target cell membranes causing lysis.

  137. DiGeorge syndrome involves 22q11 deletion causing failed development of 3rd/4th pharyngeal pouches (thymus, parathyroids).

  138. BTK mutation blocks B-cell maturation at pre-B stage, causing absent mature B-cells and immunoglobulins.

  139. Positive selection (MHC recognition) occurs in thymic cortex.

  140. Central tolerance deletes self-reactive T-cells (thymus) and B-cells (bone marrow) during development.

  141. VWF mediates platelet adhesion to collagen and carries/stabilizes factor VIII.

  142. Hemophilia A = Factor VIII deficiency; Hemophilia B (Christmas disease) = Factor IX deficiency.

  143. DIC shows elevated D-dimer (fibrin degradation), low fibrinogen (consumed), low platelets, and prolonged PT/PTT.

  144. ITP involves IgG autoantibodies against platelet glycoproteins (GPIIb/IIIa, GPIb/IX), causing splenic destruction.

  145. HIT Type II involves IgG antibodies against PF4-heparin complexes, causing platelet activation and paradoxical thrombosis despite low platelet count.

  146. Osteoporosis has reduced bone mass but normal calcium:oite ratio (normal mineralization).

  147. Osteosarcoma typically arises in the metaphysis of long bones (distal femur, proximal tibia) in adolescents during growth spurts.

  148. Codman’s triangle is periosteal elevation by tumor, seen in aggressive bone tumors like osteosarcoma.

  149. Ewing sarcoma shows lamellated “onion skin” periosteal reaction from repeated periosteal lifting.

  150. Giant cell tumor (osteoclastoma) arises in the epiphysis of long bones after growth plate closure (20–40 years), often at knee.

  151. RA typically affects small joints (MCP, PIP, wrists) symmetrically.

  152. Pannus is inflamed granulation tissue that erodes cartilage and bone in RA.

  153. Gout shows monosodium urate crystals–needle-shaped, negatively birefringent (yellow parallel to axis).

  154. HLA-B27 is strongly associated with seronegative spondyloarthropathies: ankylosing spondylitis, reactive arthritis, psoriatic arthritis, IBD-associated arthritis.

  155. Aschoff bodies are granulomatous lesions with Anitschkow cells (caterpillar cells) in rheumatic carditis following Group A streptococcal infection.

  156. Koebner phenomenon (isomorphic response) is appearance of psoriatic lesions at sites of skin trauma.

  157. Auspitz sign is pinpoint bleeding when psoriatic scales are scraped off, due to dilated capillaries in elongated dermal papillae.

  158. Tzanck smear from vesicle base shows multinucleated giant cells in herpesvirus infections (HSV, VZV).

  159. ABCDE = Asymmetry, Border irregularity, Color variation, Diameter >6mm, Evolution–warning signs for melanoma.

  160. Actinic keratosis (solar keratosis) is premalignant dysplasia that can progress to squamous cell carcinoma.

  161. The Poison Act 1919 mandates that poisons cannot be sold to anyone under 18 years of age.

  162. A poison can be natural or synthetic – there is no requirement for it to be naturally occurring.

  163. The Poison Act requires licensed sellers to maintain a Poison Register documenting all sales, including buyer details, quantity, date, and purpose.

  164. Intravenous administration delivers poison directly into the bloodstream, bypassing all absorption barriers and producing immediate systemic effects.

  165. Biotransformation (metabolism) refers to the chemical modification of poisons by body enzymes, primarily in the liver.

  166. The liver is the main organ for detoxification through enzymatic biotransformation (Phase I and II reactions).

  167. A detailed history including substance ingested, amount, time, route, and symptoms provides crucial diagnostic information.

  168. Stomach contents and wall are priority samples as they contain unabsorbed poison and show direct corrosive effects.

  169. Saturated sodium chloride (common salt) solution is the standard preservative for viscera in poisoning cases as it prevents putrefaction without interfering with chemical analysis.

  170. Diacetyl monoxime test detects organophosphate compounds by reacting with their metabolites.

  171. Atropine blocks muscarinic effects while Pralidoxime (2-PAM) reactivates inhibited acetylcholinesterase.

  172. The classic universal antidote contained activated charcoal (adsorbent), magnesium oxide (neutralizes acids), and tannic acid (precipitates alkaloids and metals).

  173. Naloxone is a competitive opioid receptor antagonist that rapidly reverses opioid toxicity including respiratory depression.

  174. BAL (Dimercaprol) chelates heavy metals including arsenic, mercury, and lead.

  175. Organophosphate compounds typically have a garlic-like odor detectable on breath and clothes.

  176. SLUDGE (Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis) represents muscarinic effects of cholinergic excess in organophosphate poisoning.

  177. Organophosphates irreversibly inhibit acetylcholinesterase, causing accumulation of acetylcholine at synapses.

  178. Miosis results from muscarinic receptor stimulation causing contraction of the pupillary sphincter muscle.

  179. Somatic death refers to complete and irreversible cessation of all vital functions (circulation, respiration, brain activity) of the body as a unified organism.

  180. Absence of pulse is uncertain because it can be temporarily absent in syncope, shock, or hypothermia while the person is still alive.

  181. Brain death requires irreversible cessation of ALL brain functions including the brainstem.

  182. Primary relaxation (primary flaccidity) occurs immediately after death due to cessation of nervous impulses maintaining muscle tone.

  183. All early postmortem changes begin almost simultaneously after death: pallor (loss of color), algor mortis (cooling), livor mortis (lividity), and rigor mortis (stiffening) start together but become evident at different times based on their visibility.

  184. Rigor mortis follows Nysten’s rule – appearing first in smaller muscles (eyelids, jaw) and progressing to larger muscles (trunk, limbs).

  185. After death, ATP depletes and lactic acid accumulates.

  186. Cadaveric spasm (instantaneous rigor) occurs immediately at death without prior relaxation, preserving the last ante-mortem posture.

  187. Heat stiffening results from coagulation of muscle proteins at high temperatures (>60°C), making it irreversible and different from ATP-dependent rigor mortis.

  188. Algor mortis means postmortem cooling as the body equilibrates with ambient temperature.

  189. The average cooling rate is approximately 1.5°F (0.8°C) per hour under standard conditions, though this varies with body size, clothing, environment, and cause of death.

  190. Greenish discoloration appears first over the right iliac fossa due to proximity of cecum (containing most bacteria) to the surface.

  191. Marbling results from hemolysis releasing hemoglobin which forms sulfhemoglobin (green-black), outlining superficial venous patterns.

  192. Putrefactive gases include hydrogen sulfide, carbon dioxide, methane, and ammonia, all produced by bacterial decomposition.

  193. Maceration is aseptic autolysis occurring in dead fetuses retained in utero or bodies in water, characterized by skin softening and peeling without putrefaction.

  194. Spalding sign is radiological overlapping of fetal skull bones due to liquefaction of brain tissue and loss of intracranial pressure in intrauterine fetal death.

  195. Adipocere (grave wax) forms through saponification – hydrolysis of body fat into fatty acids which combine with calcium and ammonia to form waxy soap-like substance.

  196. Adipocere requires warm, moist, anaerobic conditions for saponification to occur.

  197. Mummification results from rapid desiccation (drying) causing shriveling and preservation of body tissues.

  198. Hot, dry environments with good air circulation cause rapid dehydration before putrefactive bacteria can act, resulting in natural mummification.

  199. The Y-shaped incision (from both shoulders meeting at sternum, extending to pubis) provides optimal access to all body cavities.

  200. Medicolegal autopsy is performed on court/magistrate orders in cases of unnatural, sudden, or suspicious deaths.

  201. Exhumation is the legal process of disinterring (digging up) a buried body for medicolegal examination when new evidence emerges or foul play is suspected.

  202. Executive Magistrate (or judicial authority) has the power to order exhumation under Section 176 CrPC.

  203. Postmortem artifacts are changes occurring after death (during handling, autopsy, or decomposition) that can be mistaken for ante-mortem injuries or pathology.

  204. Autopsy personnel face risk of blood-borne infections (HIV, Hepatitis B/C, tuberculosis) and chemical exposure (formalin used for preservation).

  205. Hydrostatic (flotation) test determines if lungs floated in water, indicating respiration occurred before death (live birth).

  206. In many jurisdictions including under English law model, infanticide refers to killing of a child under 12 months (1 year) by the mother with disturbed mental balance.

  207. Spectroscopic identification of hemoglobin absorption bands is confirmatory for blood.

  208. Group O has no A or B antigens on RBCs, so it can be transfused to any ABO group without causing agglutination reaction.

  209. Abrasion is a superficial injury involving only the epidermis (outer skin layer), caused by friction or scraping.

  210. Stab wounds have depth greater than length/width on the skin surface, caused by pointed weapons (knives, daggers).

  211. Pilocarpine is a direct-acting muscarinic agonist used topically for glaucoma.

  212. Carbachol is a direct-acting cholinergic agonist with both muscarinic and nicotinic receptor activity; its quaternary ammonium structure prevents CNS penetration.

  213. Donepezil is a centrally acting reversible AChE inhibitor specifically used for Alzheimer’s dementia.

  214. Atropine is a competitive muscarinic antagonist that blocks excessive cholinergic stimulation (SLUDGE symptoms) in organophosphate poisoning.

  215. Edrophonium (Tensilon test) is an ultra-short-acting (2–10 minutes) AChE inhibitor used diagnostically for myasthenia gravis.

  216. Bethanechol has a methyl group substituted on the beta carbon of acetylcholine, making it resistant to hydrolysis by acetylcholinesterase.

  217. Cevimeline is a muscarinic agonist (M1 and M3 selective) specifically approved for xerostomia in Sjögren’s syndrome.

  218. Methacholine is a synthetic choline ester with predominant muscarinic activity, especially on bronchial smooth muscle.

  219. Pseudocholinesterase (butyrylcholinesterase) is synthesized in the liver and circulates in plasma.

  220. Pilocarpine causes miosis by contracting the iris sphincter muscle and contracts the ciliary muscle (accommodation), which can cause myopia.

  221. Tiotropium is a long-acting muscarinic antagonist (LAMA) with prolonged M3 receptor binding, allowing once-daily dosing for COPD.

  222. Tropicamide has lower receptor binding affinity compared to atropine, allowing quick dissociation from muscarinic receptors and short duration (4–6 hours vs. days for atropine).

  223. Glycopyrrolate is a quaternary ammonium compound that doesn’t cross the blood-brain barrier, avoiding CNS side effects (confusion, sedation).

  224. Oxybutynin is an antimuscarinic drug blocking M3 receptors in the bladder detrusor muscle, reducing urgency and frequency.

  225. Benztropine is a centrally acting antimuscarinic used in Parkinson’s disease to reduce tremor and rigidity by restoring dopamine-ACh balance in the basal ganglia.

  226. Atropa belladonna (deadly nightshade) contains tropane alkaloids (atropine, scopolamine) causing classic anticholinergic toxicity: “hot as a hare, dry as a bone, red as a beet, blind as a bat, mad as a hatter.” Digitalis causes cardiac toxicity.

  227. Scopolamine prevents motion sickness by blocking muscarinic (especially M1) receptors in vestibular nuclei and the vomiting center.

  228. Physostigmine is a tertiary amine AChE inhibitor that crosses the blood-brain barrier, reversing both central (confusion, hallucinations) and peripheral anticholinergic effects.

  229. The heart is predominantly under parasympathetic (vagal) control at rest.

  230. Ganglionic blockers prevent sympathetic outflow to blood vessels, blocking compensatory vasoconstriction during postural changes.

  231. Hexamethonium was one of the first ganglionic blockers used for severe hypertension but caused numerous side effects (orthostatic hypotension, constipation, urinary retention, dry mouth) due to non-selective autonomic blockade.

  232. Mecamylamine is a secondary amine that remains largely non-ionized at physiologic pH, allowing it to cross the lipid blood-brain barrier.

  233. Dobutamine is a selective beta-1 agonist that increases cardiac contractility (positive inotropy) with less chronotropic effect and minimal alpha-mediated vasoconstriction.

  234. Epinephrine’s actions in anaphylaxis: Alpha-1 causes vasoconstriction (reverses hypotension, reduces edema), Beta-2 causes bronchodilation (reverses bronchospasm), and Beta-1 increases cardiac output (supports blood pressure).

  235. Norepinephrine is a potent alpha-1 agonist causing peripheral vasoconstriction, which increases systemic vascular resistance and blood pressure.

  236. Phenylephrine is a pure alpha-1 agonist causing vasoconstriction and increased blood pressure.

  237. Albuterol (salbutamol) is a short-acting beta-2 agonist (SABA) with rapid onset (minutes) and short duration (4–6 hours), ideal for acute bronchospasm rescue.

  238. Ritodrine is a beta-2 selective agonist used as a tocolytic to inhibit uterine contractions in preterm labor.

  239. Prolonged sympathomimetic use causes receptor desensitization (phosphorylation, uncoupling from G-proteins) and downregulation (internalization, decreased receptor number), reducing responsiveness–tachyphylaxis.

  240. Tyramine is an indirect sympathomimetic that releases stored norepinephrine from nerve terminals.

  241. Amphetamines primarily work by entering nerve terminals and reversing dopamine/norepinephrine transporters, causing massive catecholamine efflux into synapses.

  242. At low doses, dopamine preferentially activates D1 (dopaminergic) receptors in renal and mesenteric vessels, causing vasodilation and increased renal blood flow.

  243. Prazosin is a selective alpha-1 blocker that causes vasodilation (lowering BP) and relaxes prostatic/urethral smooth muscle (improving BPH symptoms).

  244. Phenoxybenzamine forms covalent bonds with alpha receptors (both alpha-1 and alpha-2), producing irreversible, non-competitive blockade lasting 14–48 hours until new receptors synthesize.

  245. Metoprolol is beta-1 selective (“cardioselective”), preferentially blocking cardiac beta-1 receptors while relatively sparing bronchial beta-2 receptors.

  246. Chronic beta-blockade causes compensatory upregulation of beta receptors.

  247. Clonidine is a central alpha-2 agonist that stimulates alpha-2 receptors in the brainstem (nucleus tractus solitarius), reducing sympathetic outflow and lowering blood pressure and heart rate.

  248. Chronic clonidine use suppresses central sympathetic outflow.

  249. Methyldopa is a prodrug converted to alpha-methylnorepinephrine in the CNS, which stimulates brainstem alpha-2 receptors and reduces sympathetic outflow–similar to clonidine.

  250. Carvedilol is a non-selective beta-blocker with additional alpha-1 blocking activity, providing afterload reduction through vasodilation–beneficial in heart failure.

  251. Propranolol is lipophilic and readily crosses the blood-brain barrier, allowing it to reduce tremor through both central and peripheral beta-blockade.

  252. Propranolol inhibits 5′-deiodinase, the enzyme converting T4 to the more active T3 in peripheral tissues.

  253. Tamoxifen acts as an estrogen antagonist in breast tissue, blocking ER-positive breast cancer cell proliferation.

  254. Imatinib is a tyrosine kinase inhibitor specifically targeting BCR-ABL fusion protein produced by the Philadelphia chromosome translocation in CML.

  255. Cisplatin nephrotoxicity is prevented by aggressive IV saline hydration, maintaining high urine output to dilute platinum concentrations in renal tubules.

  256. Doxorubicin (anthracycline) generates free radicals via iron-dependent oxidation, causing cumulative, dose-dependent cardiomyocyte damage and heart failure.

  257. Leucovorin (folinic acid/5-formyl-THF) is a reduced folate that bypasses the methotrexate-inhibited dihydrofolate reductase, providing cells with THF for DNA/RNA synthesis.

  258. Vincristine binds tubulin and inhibits microtubule polymerization, disrupting axonal transport mechanisms essential for peripheral nerve function.

  259. Methotrexate is a folic acid analog that competitively inhibits dihydrofolate reductase (DHFR), preventing conversion of dihydrofolate to tetrahydrofolate–essential for purine and thymidine synthesis.

  260. Cyclophosphamide metabolism produces acrolein, a toxic metabolite that causes hemorrhagic cystitis.

  261. Dinoprostone (PGE2 analog) is used as a vaginal insert for cervical ripening and labor induction.

  262. Alprostadil (PGE1) causes direct vasodilation by increasing cAMP in vascular smooth muscle and inhibits platelet aggregation, improving blood flow in ischemic limbs.

  263. Low-dose aspirin irreversibly acetylates COX-1 in platelets, blocking thromboxane A2 synthesis–a potent vasoconstrictor and platelet aggregator.

  264. Montelukast is a cysteinyl leukotriene receptor antagonist (LTRA) blocking CysLT1 receptors.

  265. Zileuton inhibits 5-lipoxygenase, the enzyme converting arachidonic acid to leukotrienes.

  266. Tretinoin (all-trans-retinoic acid) is a topical retinoid that normalizes follicular keratinization, prevents comedone formation, and enhances cell turnover.

  267. Isotretinoin is a potent teratogen causing severe craniofacial abnormalities (ear, eye, skull defects), CNS malformations, cardiovascular defects, and thymic abnormalities.

  268. Permethrin 5% cream is first-line for scabies–safe for children >2 months old.

  269. Oral ivermectin is highly effective for crusted scabies when topical treatments fail due to heavy mite burden and poor penetration into thick crusts.

  270. Methotrexate causes bone marrow suppression (requires CBC monitoring) and hepatotoxicity (requires LFTs).

  271. Acitretin has an extremely long half-life, and when combined with alcohol, converts to etretinate (stored in fat for years).

  272. Adalimumab is a fully human monoclonal antibody against TNF-α, effective for both RA and psoriasis.

  273. Sickle cell anemia results from a point mutation in the beta-globin gene where glutamic acid (hydrophilic) is replaced by valine (hydrophobic) at position 6.

  274. Pack-years are calculated as (cigarettes per day ÷ 20) × years smoked.

  275. Combined therapy addresses both psychological addiction (behavioral counseling) and physical dependence (pharmacotherapy like NRT, bupropion, or varenicline), achieving 25-30% quit rates.

  276. Smokeless tobacco contains carcinogenic nitrosamines that directly contact oral mucosa, causing oral cancers.

  277. WHO provides technical guidelines, disease surveillance coordination, and policy frameworks for EPI globally.

  278. UNICEF is the world’s largest vaccine buyer, procuring vaccines for approximately 45% of children globally and managing supply chains to developing countries.

  279. IHR 2005 mandates notification within 24 hours of assessment of a potential PHEIC to enable rapid international response.

  280. Brick kiln work is classified as hazardous under ILO Convention 182 and Pakistan’s Employment of Children Act, prohibiting anyone under 18.

  281. Multiple bruises at different healing stages indicate repeated injuries over time – a hallmark of non-accidental trauma.

  282. Sexual abuse is most underreported due to stigma, shame, fear of family honor implications, and victim-blaming in Pakistani society.

  283. Approximately 70% of child laborers in Pakistan work in agriculture – cotton picking, livestock herding, and farming.

  284. Mammography remains the gold standard for breast cancer screening, reducing mortality by 20-30% in women over 40.

  285. The “esophageal cancer belt” (Central Asia including northern Pakistan) has high SCC rates due to thermal injury from hot tea (qahwa) and nitrosamines in preserved foods.

  286. VIA provides instant visual results, enabling “screen-and-treat” in single visits – critical where follow-up is poor.

  287. Primary prevention through tobacco cessation addresses the root cause – 90% of oral cancers are tobacco-related (smoking and smokeless).

  288. WHO classifies anemia prevalence ≥40% as a severe public health problem.

  289. Pakistani diets rely on unleavened wheat bread (roti) and tea, both high in phytates and tannins that inhibit iron absorption.

  290. Vitamin B12 is found almost exclusively in animal products.

  291. Pakistan’s national fortification program mandates iron (30 ppm) and folic acid (1.5 ppm) in wheat flour to combat anemia and neural tube defects.

  292. BCG provides 70-80% protection against severe disseminated TB in children (meningitis, miliary) but only 50% against pulmonary TB (A).

  293. At 6 weeks, EPI schedule includes OPV-1, Pentavalent-1 (DPT-HepB-Hib), PCV-1, and Rotavirus-1.

  294. OPV is most heat-sensitive, requiring -15 to -25°C for storage; it loses potency rapidly above +8°C.

  295. Blood products contain antibodies that neutralize live vaccines like measles, requiring a 3-month interval before vaccination.

  296. OPV induces secretory IgA in gut mucosa, preventing intestinal viral replication and environmental shedding – essential for interrupting transmission in endemic areas.

  297. Primary prevention addresses root causes – proper workstation design (adjustable chairs, appropriate table heights, monitor positions) maintains neutral spine and joint positions.

  298. The top of the monitor at eye level allows slight downward gaze (10-20°), maintaining neutral cervical spine position.

  299. Prolonged cross-legged sitting causes sustained knee flexion stress leading to cartilage damage and osteoarthritis.

  300. Cultural practices (purdah, indoor lifestyle) and covered clothing severely limit sun exposure, causing endemic vitamin D deficiency in Pakistani women (>80% affected).

  301. Universal vitamin D supplementation (400 IU/day for infants) prevents rickets cost-effectively before clinical disease develops.

  302. Osteomalacia involves defective mineralization – osteoid (bone matrix) is produced but not calcified due to vitamin D deficiency.

  303. ICF distinguishes impairment (body level), activity limitation (individual level), and participation restriction (societal level).

  304. Secondary disabilities are preventable complications from primary conditions – e.g., pressure ulcers in paraplegics, contractures in stroke patients, depression in chronic illness.

  305. Cerebral palsy primarily affects motor function, posture, and movement – classified as locomotor/physical disability.

  306. Occupational therapists specialize in ADL independence – teaching adaptive techniques for self-care, home management, and work activities.

  307. CBR utilizes community resources, family involvement, and trained community workers to provide rehabilitation locally – increasing accessibility and sustainability.

  308. Vocational rehabilitation aims to restore economic independence through job training, workplace modifications, and skill development matching residual capacities.

  309. Seatbelts prevent injury during the crash by restraining occupants – an event-phase intervention.

  310. Young children require direct supervision and physical barriers (fencing, door alarms) – they cannot protect themselves regardless of swimming ability.

  311. Original containers have warning labels; locked storage physically prevents access.

  312. Passive prevention requires no active decision-making – safer stove design inherently prevents burns.

  313. Polypharmacy, particularly sedatives, antihypertensives, and psychotropics, causes dizziness, confusion, and impaired balance – leading fall causes.

  314. Heinrich’s theory identifies five dominoes: ancestry/social environment → personal fault → unsafe act/condition → accident → injury.

  315. The hierarchy prioritizes most effective controls: eliminate the hazard if possible; substitute with less hazardous alternatives; engineer barriers/safeguards; administrative controls (procedures, training); PPE as last resort.

  316. MPOWER stands for: Monitor tobacco use, Protect from smoke (smoke-free policies), Offer cessation help, Warn about dangers, Enforce bans on advertising, Raise taxes. “P” specifically means protecting people from secondhand smoke through smoke-free public spaces.

  317. School-based supplementation reaches adolescent girls directly through existing infrastructure with regular attendance.

  318. Pakistan’s Employment of Children Act sets 14 as minimum age for any employment, aligning with ILO Convention 138.

  319. Pakistan has high oral cancer rates (smokeless tobacco) and esophageal cancer (hot beverages, dietary factors in northern regions).

  320. OPV requires freezer storage (-15 to -25°C) as the live attenuated poliovirus is extremely heat-sensitive.

  321. Standing for long periods causes venous pooling (varicose veins) and increased lumbar spine loading (low back pain).

  322. The CBR matrix has five components: Health, Education, Livelihood, Social, and Empowerment.

  323. Speeding contributes to approximately 30% of road traffic deaths – higher speed increases both crash likelihood and injury severity.

  324. BRCA1 is a tumor suppressor gene essential for homologous recombination repair of DNA double-strand breaks.

  325. Tumor grading evaluates the degree of cellular differentiation and mitotic activity (how abnormal cells appear), while staging (e.g., TNM system) assesses anatomical spread including tumor size, lymph node involvement, and metastases.

  326. X-linked agammaglobulinemia (Bruton’s disease) results from BTK mutations causing arrested B-cell maturation at the pre-B stage.

  327. Sickle cell disease results from a point mutation in the β-globin gene causing substitution of glutamic acid (hydrophilic) with valine (hydrophobic) at position 6.

  328. Methotrexate inhibits dihydrofolate reductase, depleting active folate (tetrahydrofolate) required for thymidine synthesis and DNA replication.

  329. Immune thrombocytopenic purpura (ITP) is characterized by antiplatelet antibodies causing peripheral platelet destruction, often post-viral in children.

  330. Chronic lymphocytic leukemia (CLL) presents in elderly patients with lymphocytosis of mature CD5+/CD19+/CD23+ B cells and characteristic smudge cells (fragile lymphocytes).

  331. DIC shows consumption of platelets and clotting factors (prolonged PT/aPTT), low fibrinogen, elevated D-dimer (fibrin degradation), and microangiopathic hemolytic anemia (schistocytes).

  332. Hemophilia A (factor VIII deficiency) is X-linked recessive, affecting males primarily while females are carriers.

  333. Beta-thalassemia minor shows microcytic anemia with elevated HbA2 (>3.5%) and often elevated HbF due to reduced β-globin synthesis.

  334. G6PD deficiency causes oxidative hemolysis triggered by drugs (primaquine, sulfonamides), infections, or fava beans.

  335. PNH results from acquired PIGA gene mutations causing loss of GPI-anchored proteins (CD55/CD59), leading to complement-mediated hemolysis.

  336. Polycythemia vera can progress to “spent phase” or post-polycythemic myelofibrosis characterized by marrow fibrosis, cytopenias, splenomegaly, and teardrop cells (dacrocytes).

  337. CML is defined by the Philadelphia chromosome t(9;22)(q34;q11), producing the BCR-ABL1 fusion protein with constitutive tyrosine kinase activity promoting proliferation.

  338. B-ALL is the most common childhood malignancy, characterized by TdT+ (immature) lymphoblasts expressing B-cell markers (CD10, CD19, CD22).

  339. Multiple myeloma presents with the classic “CRAB” criteria: hyperCalcemia, Renal insufficiency, Anemia, and Bone lesions.

  340. Reed-Sternberg cells (binucleated with “owl-eye” nucleoli) in a mixed inflammatory background are pathognomonic for classical Hodgkin lymphoma.

  341. Burkitt lymphoma is a highly aggressive B-cell lymphoma with t(8;14) causing MYC overexpression, resulting in extremely high proliferation (Ki-67 ~100%) and “starry-sky” pattern.

  342. Anti-CCP antibodies are highly specific (>95%) for rheumatoid arthritis and are associated with erosive disease.

  343. Ankylosing spondylitis is a seronegative spondyloarthropathy strongly associated with HLA-B27, presenting with inflammatory back pain (improves with activity) and bilateral sacroiliitis.

  344. Monosodium urate crystals in gout are needle-shaped and negatively birefringent (yellow when parallel to the slow ray of the compensator).

  345. Acute rheumatic fever results from molecular mimicry where antibodies against Group A Streptococcus M protein cross-react with cardiac myosin, valve glycoproteins, and neuronal tissue.

  346. Anti-centromere antibodies are highly specific for limited cutaneous systemic sclerosis (CREST: Calcinosis, Raynaud, Esophageal dysmotility, Sclerodactyly, Telangiectasia).

  347. Osteoarthritis shows “wear and tear” degeneration with cartilage fibrillation, erosion, and eburnation (polished subchondral bone).

  348. Osteosarcoma is the most common primary bone malignancy in adolescents, arising in the metaphysis of long bones.

  349. Multiple myeloma cells secrete factors including RANKL (receptor activator of NF-κB ligand) and MIP-1α, which activate osteoclasts and inhibit osteoblasts, causing purely lytic bone lesions.

  350. Ewing sarcoma presents in children/adolescents with diaphyseal bone lesions, “onion skin” periosteal reaction, and small round blue cell morphology. t(11;22)(q24;q12) creates the EWS-FLI1 fusion.

  351. Giant cell tumor (osteoclastoma) occurs in skeletally mature adults (20-40 years), located in the epiphysis of long bones with “soap bubble” radiolucency.

  352. Chondrosarcoma is a malignant cartilage-producing tumor common in the pelvis, proximal femur, and shoulder. “Popcorn” calcifications are characteristic.

  353. Vertebral osteomyelitis in adults typically results from hematogenous spread, particularly in IV drug users.

  354. Osteoporosis shows reduced bone mass with normal mineralization, leading to fragility fractures.

  355. Paget disease is characterized by disorganized bone remodeling with mixed lytic and sclerotic phases.

  356. Duchenne muscular dystrophy is X-linked recessive, caused by mutations in the dystrophin gene (DMD).

  357. Psoriasis shows characteristic silvery scales, well-demarcated plaques, and nail pitting.

  358. Erythema multiforme presents with “targetoid” lesions, commonly triggered by HSV infection.

  359. Basal cell carcinoma is the most common skin cancer, presenting as a pearly papule with telangiectasias and rolled borders on sun-exposed areas.

  360. Squamous cell carcinoma arises from chronically sun-damaged skin or mucosa (especially lower lip).

  361. Breslow thickness (tumor depth from granular layer to deepest invasive cell) is the most important prognostic factor for melanoma.

  362. Kaposi sarcoma is caused by HHV-8 infection and occurs in immunocompromised patients (AIDS-associated KS).

  363. HSV-1 causes recurrent “cold sores” presenting as grouped vesicles on erythematous base.

  364. Molluscum contagiosum is a poxvirus infection presenting as umbilicated papules.

  365. Erysipelas is a superficial cellulitis caused by Group A Streptococcus, characterized by sharply demarcated erythema, warmth, and rapid spread.

  366. Tinea corporis (“ringworm”) is caused by dermatophytes (Trichophyton, Microsporum, Epidermophyton) presenting as annular plaques with central clearing and raised scaly borders.

  367. Pityriasis versicolor is caused by Malassezia (lipophilic yeast) presenting with hypo/hyperpigmented macules on the trunk.

  368. Delayed hemolytic transfusion reaction occurs days to weeks after transfusion due to anamnestic response to minor RBC antigens (Kidd, Duffy, Kell).

  369. SLE is the prototype of Type III hypersensitivity with immune complex deposition causing complement activation (low C3/C4) and tissue damage in multiple organs.

  370. Anaphylaxis is a Type I hypersensitivity reaction mediated by IgE bound to mast cells and basophils.

  371. Frameshift mutations result from insertions or deletions (not multiples of 3) that alter the reading frame, leading to completely different amino acid sequence downstream.

  372. Well-differentiated liposarcoma (atypical lipomatous tumor) shows mature adipocytes with nuclear atypia, scattered lipoblasts, and fibrous septa.

  373. Organophosphates irreversibly inhibit acetylcholinesterase, causing accumulation of acetylcholine at muscarinic and nicotinic receptors, leading to the SLUDGE syndrome (Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis) and miosis.

  374. At rest, the heart is dominated by parasympathetic (vagal) tone via muscarinic receptors, but ganglionic transmission uses nicotinic receptors.

  375. Dry mouth (decreased salivation), mydriasis (dilated pupils), and tachycardia are classic antimuscarinic effects.

  376. Sympathetic preganglionic neurons originate in the thoracolumbar spinal cord (T1-L2) and synapse in paravertebral/prevertebral ganglia close to the cord, making preganglionic fibers short and postganglionic fibers long.

  377. Adrenal medullary chromaffin cells are modified postganglionic sympathetic neurons derived from neural crest cells.

  378. The vagus nerve (CN X) provides parasympathetic innervation to thoracic and abdominal organs up to the splenic flexure of the transverse colon.

  379. RDW measures anisocytosis (variation in RBC size).

  380. EPO is produced primarily (90%) by peritubular interstitial fibroblasts in the renal cortex in response to hypoxia.

  381. Mature RBCs lack mitochondria, so they cannot perform oxidative phosphorylation, Krebs cycle, or beta-oxidation.

  382. The spleen is the primary site of extravascular hemolysis (destruction of old/abnormal RBCs).

  383. Increased 2,3-DPG binds to deoxyhemoglobin, stabilizing the T (tense) state, which reduces hemoglobin’s affinity for oxygen.

  384. Infectious mononucleosis caused by EBV classically presents in young adults with fever, pharyngitis, and lymphadenopathy.

  385. Neutrophils have a very short circulating half-life of approximately 6-10 hours before they marginate and migrate into tissues where they survive 1-2 days.

  386. Eosinophils contain crystalloid granules rich in Major Basic Protein (MBP), eosinophil cationic protein, and eosinophil peroxidase – all toxic to parasitic helminths.

  387. Neutrophil extravasation follows a precise sequence: (1) Rolling – mediated by selectins (E-selectin, P-selectin) on endothelium binding to sialyl-Lewis X on neutrophils; (2) Firm adhesion – integrins (LFA-1, Mac-1) bind to ICAM-1 on endothelium; (3) Diapedesis – transmigration through vessel wall via PECAM-1; (4) Chemotaxis – directed migration toward chemoattractants (IL-8, C5a, LTB4).

  388. Chronic Granulomatous Disease is caused by defective NADPH oxidase, preventing the respiratory burst needed to generate superoxide and other reactive oxygen species for intracellular killing.

  389. Von Willebrand Disease (vWD) is the most common inherited bleeding disorder. vWF mediates platelet adhesion to exposed subendothelium and carries Factor VIII.

  390. Dense (delta) granules contain ADP, ATP, serotonin, calcium, and polyphosphates.

  391. Aspirin irreversibly acetylates COX-1 in platelets, blocking conversion of arachidonic acid to prostaglandin H2 (precursor of TXA2).

  392. Type I (slow-twitch) fibers are designed for sustained, endurance activities.

  393. During contraction, actin filaments slide over myosin toward the M line.

  394. The length-tension relationship states that force depends on actin-myosin overlap.

  395. Acetylcholinesterase (AChE) is concentrated in the synaptic cleft at the NMJ and rapidly hydrolyzes ACh into acetate and choline, terminating signal transmission.

  396. Myasthenia gravis is caused by IgG autoantibodies against postsynaptic nicotinic ACh receptors at the NMJ, reducing available receptors through complement-mediated destruction, increased internalization, and functional blockade.

  397. In the cross-bridge cycle, after the power stroke, myosin remains bound to actin in a “rigor state” until a new ATP molecule binds to the myosin head, causing detachment.

  398. Lambert-Eaton Myasthenic Syndrome (LEMS) is caused by antibodies against presynaptic voltage-gated calcium channels (VGCC), reducing ACh release.

  399. N-Acetylcysteine (NAC) is the specific antidote for acetaminophen poisoning.

  400. Pralidoxime (2-PAM) reactivates acetylcholinesterase by removing the organophosphate molecule from the enzyme before “aging” occurs (irreversible binding, ~24-48 hours).